News Medical11h
Biomarker test can improve neonatal outcomes for preterm births
Preterm birth - defined as delivery before the 37th week of pregnancy - is one of the leading causes of infant deaths in the ...
GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction
Primary endpoint met, GH001 led to an ultra-rapid anti-depressant effect with a significant placebo-adjusted MADRS reduction from baseline of ...